-
Merck’s Ebola vaccine widely used in latest outbreak: WHO official
fiercepharma
December 12, 2018
Merck’s Ebola vaccine rVSV-ZEBOV has been utilized in several outbreaks, including an ongoing one in the Democratic Republic of Congo...
-
Group calls for flu shots over AstraZeneca's FluMist this year
fiercepharma
December 12, 2018
AstraZeneca’s FluMist has missed two flu seasons in the U.S. due to efficacy problems, and now a group of pediatric experts have recommended injected vaccines over the nasal option for the upcoming season.
-
Moderna picks up FDA vaccine official Wellington Sun
fiercepharma
December 12, 2018
Moderna Therapeutics, carrying a valuation in the billions of dollars and testing several mRNA vaccine programs in early stages, has a new leader in vaccines.
-
Needed vaccines unlikely at current funding levels, study says
fiercepharma
December 12, 2018
Despite hundreds of pipeline programs in testing and billions of dollars spent annually...
-
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S.
fiercepharma
December 11, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the mission of bringing some novel...
-
Emergent and Valneva's Zika vaccine clears phase 1
fiercepharma
December 11, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
-
Why China's flu vaccine supply is suffering this season
fiercepharma
December 11, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down...
-
Anti-vaccine sentiment causing first deaths, expert says
fiercepharma
December 11, 2018
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.
-
Citing low vaccine trust, experts warn of measles in Philippines
fiercepharma
December 11, 2018
Since Sanofi disclosed that its dengue vaccine Dengvaxia can cause more serious infections in certain people, distrust in vaccines has mounted in the Philippines...
-
J&J, Merck chip in for $100M U.K. vaccine center
fiercepharma
December 11, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...